STIRPE, FIORENZO
STIRPE, FIORENZO
DIP. DI PATOLOGIA SPERIMENTALE
A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein)
1996 Olivieri F.; Prasad V.; Valbonesi P.; Srivastava S.; Ghosal-Chowdhury P.; Barbieri L.; Bolognesi A.; Stirpe F.
Activities associated with the presence of ribosome-inactivating proteins increase in senescent and stressed leaves
1996 Stirpe F.; Barbieri L.; Gorini P.; Valbonesi P.; Bolognesi A.; Polito L.
Adenine glycosylase activity in mammalian tissues: an equivalent of ribosome-inactivating proteins
2001 Luigi Barbieri; Paola Valbonesi; Marco Bondioli; Marylin Lugo Alvarez; Paola Dal Monte; Maria Paola Landini; Fiorenzo Stirpe
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
1999 Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.; Gobbi M.; Stirpe F.
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
1996 Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B.; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B.
Aumento della xantina ossidoreduttasi sierica dopo trapianto di fegato
2005 Pierleoni A.; Musiani S.; Battelli M.G.; Ravaioli M.; Stirpe F.
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1
1992 Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; Stirpe F.; Gobbi M.
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation
1992 Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.; Stein H.; Flenghi L.; Martelli M.F.; Stirpe F.
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia
2005 Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstein A.L.; Stirpe F.; Battelli M.G.; Malavasi F.
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae)
2007 Stirpe F.; Bolognesi A.; Bortolotti M.; Farini V.; Lubelli C.; Pelosi E.; Polito L.; Dozza B.; Strocchi P.; Chambery A.; Parente A.; Barbieri L.
Crystallization and preliminary X-ray diffraction analysis of two ribosome-inactivating proteins: Lychnin and dianthin 30
2003 Fermani S.; Falini G.; Ripamonti A.; Bolognesi A.; Polito L.; Stirpe F.
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
2003 Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Polito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B.
Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria
2004 GIRBES T.; FERRERAS J.M.; ARIAS F.J.; STIRPE F.
Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay
2006 Lubelli C.; Chatgilialoglu A.; Bolognesi A.; Strocchi P.; Colombatti M.; Stirpe F.
Distribuzione dell’attività lectinica e tossica in piante appartenenti al genere Adenia (Passifloraceae)
2005 Lubelli C.; Pelosi E.; Polito L.; Ciani M.; Bolognesi A.; Barbieri L.; Stirpe F.
Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins
1996 Vooijs W.C.; Post J.; Wijdenes J.; Schuurman H.-J.; Bolognesi A.; Polito L.; Stirpe F.; Bast E.J.E.G.; De Gast G.C.
Enzymatic activity of toxic and non toxic type 2 ribosome-inactivating proteins
2004 BARBIERI L.; CIANI M.; GIRBES T.; LIU W.Y.; VAN DAMME E.J.; PEUMANS W.J.; STIRPE F.
Epratuzumab/saporin-S6: a new anti-CD22 immunotoxin with a potent antitumour activity.
2004 Polito L.; Farini V.; Zinzani P.L.; Stirpe F.; Bolognesi A.
Evaluation of immunotoxins containing single-chain ribosome- inactivating proteins and an anti-CD22 monoclonal antibody (OM124): In vitro and in vivo studies
1998 Bolognesi A.; Tazzari P.L.; Olivieri F.; Polito L.; Lemoli R.; Terenzi A.; Pasqualucci L.; Falini B.; Stirpe F.
Expression of CTLA-4 in non-human primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.
2004 PALMISANO GL; TAZZARI PL; COZZI E; BOLOGNESI A.; POLITO L; SEVESO M; ANCONA E; RICCI F; CONTE R; STIRPE F; FERRARA GB; PISTILLO MP.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein) | Olivieri F.; Prasad V.; Valbonesi P.; Srivastava S.; Ghosal-Chowdhury P.; Barbieri L.; Bolognesi ...A.; Stirpe F. | 1996-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
Activities associated with the presence of ribosome-inactivating proteins increase in senescent and stressed leaves | Stirpe F.; Barbieri L.; Gorini P.; Valbonesi P.; Bolognesi A.; Polito L. | 1996-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
Adenine glycosylase activity in mammalian tissues: an equivalent of ribosome-inactivating proteins | Luigi Barbieri; Paola Valbonesi; Marco Bondioli; Marylin Lugo Alvarez; Paola Dal Monte; Maria Pao...la Landini; Fiorenzo Stirpe | 2001-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins | Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.;... Gobbi M.; Stirpe F. | 1999-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice | Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B....; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B. | 1996-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Aumento della xantina ossidoreduttasi sierica dopo trapianto di fegato | Pierleoni A.; Musiani S.; Battelli M.G.; Ravaioli M.; Stirpe F. | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 | Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; S...tirpe F.; Gobbi M. | 1992-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation | Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.;... Stein H.; Flenghi L.; Martelli M.F.; Stirpe F. | 1992-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia | Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstei...n A.L.; Stirpe F.; Battelli M.G.; Malavasi F. | 2005-01-01 | JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS | - | 1.01 Articolo in rivista | - |
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) | Stirpe F.; Bolognesi A.; Bortolotti M.; Farini V.; Lubelli C.; Pelosi E.; Polito L.; Dozza B.; St...rocchi P.; Chambery A.; Parente A.; Barbieri L. | 2007-01-01 | TOXICON | - | 1.01 Articolo in rivista | - |
Crystallization and preliminary X-ray diffraction analysis of two ribosome-inactivating proteins: Lychnin and dianthin 30 | Fermani S.; Falini G.; Ripamonti A.; Bolognesi A.; Polito L.; Stirpe F. | 2003-01-01 | ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY | - | 1.01 Articolo in rivista | - |
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells | Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Pol...ito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B. | 2003-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria | GIRBES T.; FERRERAS J.M.; ARIAS F.J.; STIRPE F. | 2004-01-01 | MINI-REVIEWS IN MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay | Lubelli C.; Chatgilialoglu A.; Bolognesi A.; Strocchi P.; Colombatti M.; Stirpe F. | 2006-01-01 | ANALYTICAL BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
Distribuzione dell’attività lectinica e tossica in piante appartenenti al genere Adenia (Passifloraceae) | Lubelli C.; Pelosi E.; Polito L.; Ciani M.; Bolognesi A.; Barbieri L.; Stirpe F. | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins | Vooijs W.C.; Post J.; Wijdenes J.; Schuurman H.-J.; Bolognesi A.; Polito L.; Stirpe F.; Bast E.J....E.G.; De Gast G.C. | 1996-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
Enzymatic activity of toxic and non toxic type 2 ribosome-inactivating proteins | BARBIERI L.; CIANI M.; GIRBES T.; LIU W.Y.; VAN DAMME E.J.; PEUMANS W.J.; STIRPE F. | 2004-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
Epratuzumab/saporin-S6: a new anti-CD22 immunotoxin with a potent antitumour activity. | Polito L.; Farini V.; Zinzani P.L.; Stirpe F.; Bolognesi A. | 2004-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Evaluation of immunotoxins containing single-chain ribosome- inactivating proteins and an anti-CD22 monoclonal antibody (OM124): In vitro and in vivo studies | Bolognesi A.; Tazzari P.L.; Olivieri F.; Polito L.; Lemoli R.; Terenzi A.; Pasqualucci L.; Falini... B.; Stirpe F. | 1998-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Expression of CTLA-4 in non-human primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies. | PALMISANO GL; TAZZARI PL; COZZI E; BOLOGNESI A.; POLITO L; SEVESO M; ANCONA E; RICCI F; CONTE R; ...STIRPE F; FERRARA GB; PISTILLO MP. | 2004-01-01 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | - | 1.01 Articolo in rivista | - |